3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

BRLI

Started by eliteG, June 26, 2006, 04:08:47 AM

Previous topic - Next topic

eliteG

BRLI(nasdaq) - Bio-Reference Laboratories Inc.

Mkt Cap:              280M
Float:                 10.66M

Profile:  The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complimentary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution to physicians which includes disease management, laboratory reporting and ordering, as well as claims and eligibility processing through CareEvolve, its web-based healthcare portal.

Company Website[/url]


What makes this stock "On Fire"?

BRLI is giving off huge signs of strength from its technical movement... price + volume.  Inside this strong technical shell lies great fundamentals.  Check out this consistent growth:



Last quarter was hot!

QuoteBio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues
Thursday June 8, 8:30 am ET
Company Reports 18% Increase in Net Revenues and 93% Increase in Fully Taxed Net Income in Q2 Comparisons of FY06 to FY05
http://phx.corporate-ir.net/phoenix.zhtml?c=84759&p=irol-newsArticle&ID=870332&highlight=
[/b]

Technicals
The charts for BRLI portray an ascending channel/rising wedge breakout on volume about to attack all time highs.


All History Chart  



----------------------------------------------------------------------

3-year weekly  


----------------------------------------------------------------------

7-month  



Trade Plan

The chart for BRLI has already started its ascent making it a tough buy.  It could definately pull-back to support around 20 but we are willing to risk that 7% to make sure it doesn't run away from us.

BRLI seems to be setting up for a nice run.. and the fundamentals look great.  Lets make sure to add this to the portfolio tomorrow.


We will buy BRLI on Monday 6/26

la-onda

additional information (6slides):
http://www.knobias.com/research.pdf?id=5788

&

BRLI: To Automate HIV Testing Will be First in Region
Friday , June 23, 2006 08:37 ET

Bio-Reference Laboratories (BRLI) will service approximately 3 million patients this fiscal year. And now, the Bio-Reference Labs will be the first in the region to have a fully automated molecular diagnostics test system for HIV-1 ribonucleic acid (RNA) for viral load monitoring -- the Roche Diagnostics COBAS(R) AmpliPrep / COBAS AMPLICOR HIV-1 MONITOR test, version 1.5.

nullzero

BRLI looks good anything to do with health care and stuff for the sick and elderly will be in great demand in the upcoming years with a record number of people retiring.

eliteG

update BRLI:

We got our position now in this hot looking stock.  Lets see if it can breakout of 22 this week.  ;)

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: n/a
Target: n/a
------

la-onda

short update:
BRLI: Short Interest DN 1.6% to 910.5K in Jun 2006
Monday , June 26, 2006 16:16 ET

According to new short interest data from NASDAQ, short interest for Bio-Reference Laboratories Inc (NasdaqNM: BRLI) DECREASED 1.6% to 910,459 shares for the month ended mid-June, 2006.

SYMBOL               MAY            JUNE          CHANGE       %CHANGE   DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
BRLI             924,973         910,459         -14,514        -1.57%           5

Based on BRLI's 20-day average daily share volume of 199,334, it would require approximately 5 day(s) of buying to cover this short interest.

eliteG


update BRLI:

BRLI fell back with the market today.  We expect it to see a strong rebound soon.  Lets place a stop just in case.  ;)

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: stop @ 19.19
Target: n/a
------

eliteG


update BRLI:

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: stop @ 19.19
Target: n/a
------

eliteG


update BRLI:

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: stop @ 19.19
Target: n/a
------

eliteG


update BRLI:

A nice hammer created today.  We will push the stop higher when we get hammer confirmation(a close above the high of the hammer).  Nice steady heavy volume on this position.

This news was released today and it is an important read about new Nasdaq tiers:

------------------------
BioReference Laboratories Announces Its Inclusion in the New NASDAQ Global Select Market
Tuesday July 11, 11:43 am ET
http://biz.yahoo.com/bw/060711/20060711005841.html?.v=1

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--July 11, 2006--BioReference Laboratories, Inc. (NASDAQ: BRLI - News) today announced that its common stock has been selected for inclusion on the new NASDAQ Global Select Market. The NASDAQ Global Select Market has the highest initial listing standards of any exchange in the world based on financial and liquidity requirements. The Company, which had been listed on the NASDAQ National Market, will continue to trade under the symbol "BRLI".

On July 3, NASDAQ-listed companies were reclassified under three listing tiers -- NASDAQ Global Select Market, NASDAQ Global Market, and NASDAQ Capital Market. NASDAQ also plans to launch indexes based on these new tiers.

"BioReference is proud to have met the standards required to be listed on the highest of the new NASDAQ tiers - the Global Select Market," said Marc D. Grodman, MD, CEO. "NASDAQ has raised the bar in terms of listing qualifications. BioReference has made tremendous progress over the past decade and it is important to both our employees and our shareholders that the NASDAQ recognizes our impressive financial results by including us in the market with the highest listing standards in the world."

NASDAQ announced the new three tier listing classification in February 2006. All three market tiers will maintain rigorous listing and corporate governance standards. For additional information about the NASDAQ Global Select Market, please go to: www.nasdaq.com/GlobalSelect...
---------------------

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: stop @ 19.19
Target: n/a
------

nullzero

Nice close on BRLI up +.26 (1.23%) on this horrible market day. Bought BRLI today at 21.10

eliteG


update BRLI:

Hammer was confirmed so let us move the stock higher.  ;)

------
Position: bought BRLI @ 21.50 on 06/26/2006
Order: Hold
Exit: stop @ 19.92
Target: n/a
------


nullzero

BRLI picking up some steam today on good volume!  ;)

nullzero

BRLI continue its move up close at 22.12 ;), approaching that 52wk high in a market like this!

Terliso

Hit New high ;)